Global Multi Dose Dry Powder Inhaler Device Market Growth 2025-2031
Description
The global Multi Dose Dry Powder Inhaler Device market size is predicted to grow from US$ 589 million in 2025 to US$ 807 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
A Multi-Dose Dry Powder Inhaler (DPI) Device is a type of inhalation device used to deliver medication in the form of a dry powder to the lungs. Unlike traditional metered-dose inhalers (MDIs) that use a propellant, DPIs rely on the patient’s inhalation to create airflow that carries the powdered medication into the lungs.
United States market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Multi Dose Dry Powder Inhaler Device players cover Aptar, Nemera, Vectura Group Ltd, Team Consulting, Hovione, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Multi Dose Dry Powder Inhaler Device Industry Forecast” looks at past sales and reviews total world Multi Dose Dry Powder Inhaler Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Multi Dose Dry Powder Inhaler Device sales for 2025 through 2031. With Multi Dose Dry Powder Inhaler Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi Dose Dry Powder Inhaler Device industry.
This Insight Report provides a comprehensive analysis of the global Multi Dose Dry Powder Inhaler Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi Dose Dry Powder Inhaler Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi Dose Dry Powder Inhaler Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi Dose Dry Powder Inhaler Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi Dose Dry Powder Inhaler Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Multi Dose Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blister multidose DPI
Reservoir multidose DPI
Segmentation by Application:
Asthma
COPD
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Aptar
Nemera
Vectura Group Ltd
Team Consulting
Hovione
GlaxoSmithKline
AstraZeneca
Chiesi
Vectura
Key Questions Addressed in this Report
What is the 10-year outlook for the global Multi Dose Dry Powder Inhaler Device market?
What factors are driving Multi Dose Dry Powder Inhaler Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multi Dose Dry Powder Inhaler Device market opportunities vary by end market size?
How does Multi Dose Dry Powder Inhaler Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
A Multi-Dose Dry Powder Inhaler (DPI) Device is a type of inhalation device used to deliver medication in the form of a dry powder to the lungs. Unlike traditional metered-dose inhalers (MDIs) that use a propellant, DPIs rely on the patient’s inhalation to create airflow that carries the powdered medication into the lungs.
United States market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Multi Dose Dry Powder Inhaler Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Multi Dose Dry Powder Inhaler Device players cover Aptar, Nemera, Vectura Group Ltd, Team Consulting, Hovione, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Multi Dose Dry Powder Inhaler Device Industry Forecast” looks at past sales and reviews total world Multi Dose Dry Powder Inhaler Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Multi Dose Dry Powder Inhaler Device sales for 2025 through 2031. With Multi Dose Dry Powder Inhaler Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi Dose Dry Powder Inhaler Device industry.
This Insight Report provides a comprehensive analysis of the global Multi Dose Dry Powder Inhaler Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi Dose Dry Powder Inhaler Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi Dose Dry Powder Inhaler Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi Dose Dry Powder Inhaler Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi Dose Dry Powder Inhaler Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Multi Dose Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blister multidose DPI
Reservoir multidose DPI
Segmentation by Application:
Asthma
COPD
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Aptar
Nemera
Vectura Group Ltd
Team Consulting
Hovione
GlaxoSmithKline
AstraZeneca
Chiesi
Vectura
Key Questions Addressed in this Report
What is the 10-year outlook for the global Multi Dose Dry Powder Inhaler Device market?
What factors are driving Multi Dose Dry Powder Inhaler Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multi Dose Dry Powder Inhaler Device market opportunities vary by end market size?
How does Multi Dose Dry Powder Inhaler Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
92 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Multi Dose Dry Powder Inhaler Device by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Multi Dose Dry Powder Inhaler Device by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
